H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Census population 2,693,976. Illinois Medicare wound biologics: National Government Services (NGS) (J6). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed Chicago clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a Chicago storefront.
Platelet Rich Plasma (PRP) Therapy in Chicago, IL for clinics & physicians. PRP therapy systems with 1-min… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Census city-proper population is 2,693,976. If you are adding platelet rich plasma therapy, start with that epidemiology and with National Government Services (NGS) (J6) — not with a “near me” clinic listing. Hawk Medical ships nationwide; Joe Bradley’s own practice uses the same product classes.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)CDC PLACES (2023, crude) estimates 12% of adults in Chicago have diagnosed diabetes — about even with the U.S. 12% figure. Adult obesity in Chicago is 32.6% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. Adult arthritis here is 19.6% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. Payer geography: J6 / National Government Services (NGS), sibling states MN, WI. Illinois Department of Public Health is the public-health home. We will not mash those grains into a fake “demand score.”
Vendor consolidation is boring on purpose: one account, IFUs filed, J6 articles mapped. 13.6% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Pricing scripts have to match that mix. We will help write them. We will not book your patients.
CDC PLACES (2023, crude prevalence) estimates 12% of adults — about even with the U.S. 12% figure. Obesity is 32.6%; arthritis is 19.6%. That is place-level BRFSS modeling, not a clinic census and not a Chicago trial.
The 96.5% figure is a product-level clinical experience statistic published on our wound-care materials — not a city-specific trial. Your outcomes will depend on patient selection, offloading, and follow-up.
CDC estimates 12% of the U.S. population has diabetes (40.1 million people, 2023). America's Health Rankings (BRFSS 2024) shows state adult rates from Colorado 8.4% to West Virginia 18.4%. We do not publish a made-up city diabetes count. Use national/state published rates plus your panel.
Illinois is J6. A sister clinic in another state may be a different contractor with different CTP articles. Do not assume one utilization policy ports. We map both if you operate across MACs.
If you operate in Illinois and another MAC state, say it on the first call. J6 will not port 1:1. We would rather split utilization than watch a sister clinic copy Chicago tickets into the wrong jurisdiction.
Contact us to learn how Hawk Medical supports practices in Chicago, IL.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for Chicago is J6 geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for Chicago — about even with the U.S. 12% figure. Planning input, not an outcomes claim.
Illinois Part B wound biologics follow this contractor (siblings: MN, WI). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in Chicago. Useful for joint-program math; still needs a diagnosis and privileging.
No Chicago storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.